These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30322558)

  • 21. Au nanoparticles/PAMAM dendrimer functionalized wired ethyleneamine-viologen as highly efficient interface for ultra-sensitive α-fetoprotein electrochemical immunosensor.
    Kavosi B; Hallaj R; Teymourian H; Salimi A
    Biosens Bioelectron; 2014 Sep; 59():389-96. PubMed ID: 24755256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.
    El-Abd N; Fawzy A; Elbaz T; Hamdy S
    Tumour Biol; 2016 Jan; 37(1):211-6. PubMed ID: 26189841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
    Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.
    Ge T; Shen Q; Wang N; Zhang Y; Ge Z; Chu W; Lv X; Zhao F; Zhao W; Fan J; Qin W
    Med Oncol; 2015 Mar; 32(3):59. PubMed ID: 25652109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of pancreatitis-associated protein as a serum marker of hepatocellular carcinoma: comparison with alpha-fetoprotein.
    Montalto G; Iovanna JL; Soresi M; Dusetti N; Carroccio A; Barthelemy-Bialas S; Cartabellotta A; Dagorn JC
    Oncology; 1998; 55(5):421-5. PubMed ID: 9732219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma.
    Gao G; Dong F; Xu X; Hu A; Hu Y
    Int J Clin Exp Pathol; 2015; 8(9):11379-85. PubMed ID: 26617863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.
    Zhang A; Yin C; Wang Z; Zhang Y; Zhao Y; Li A; Sun H; Lin D; Li N
    J Int Med Res; 2016 Dec; 44(6):1414-1423. PubMed ID: 27885040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma.
    Wang M; Devarajan K; Singal AG; Marrero JA; Dai J; Feng Z; Rinaudo JA; Srivastava S; Evans A; Hann HW; Lai Y; Yang H; Block TM; Mehta A
    Cancer Prev Res (Phila); 2016 Feb; 9(2):172-9. PubMed ID: 26712941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
    Nakao A; Virji A; Iwaki Y; Carr B; Iwatsuki S; Starzl E
    Hepatogastroenterology; 1991 Oct; 38(5):450-3. PubMed ID: 1722483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
    Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
    World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 8-Quinolineboronic acid as a potential phosphorescent molecular switch for the determination of alpha-fetoprotein variant for the prediction of primary hepatocellular carcinoma.
    Liu JM; Li FM; Liu ZB; Lin CQ; Lin SQ; Lin LP; Wang XX; Li ZM
    Anal Chim Acta; 2010 Mar; 663(2):184-9. PubMed ID: 20206009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
    Huang S; Jiang F; Wang Y; Yu Y; Ren S; Wang X; Yin P; Lou J
    Tumour Biol; 2017 Jun; 39(6):1010428317705763. PubMed ID: 28621228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.
    Yi X; Yu S; Bao Y
    Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple and robust diagnosis of early, small and AFP-negative primary hepatic carcinomas: an integrative approach of serum fluorescence and conventional blood tests.
    Wang T; Zhang KH; Hu PP; Huang ZY; Zhang P; Wan QS; Huang DQ; Lv NH
    Oncotarget; 2016 Sep; 7(39):64053-64070. PubMed ID: 27590520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A sensitive, universal and homogeneous method for determination of biomarkers in biofluids by resonance light scattering correlation spectroscopy (RLSCS).
    Lan T; Dong C; Huang X; Ren J
    Talanta; 2013 Nov; 116():501-7. PubMed ID: 24148436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
    Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK
    Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis.
    Caviglia GP; Ribaldone DG; Abate ML; Ciancio A; Pellicano R; Smedile A; Saracco GM
    Scand J Gastroenterol; 2018 Jun; 53(6):734-740. PubMed ID: 29667463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant biomarkers for the management of hepatocellular carcinoma.
    Kondo Y; Kimura O; Shimosegawa T
    Clin J Gastroenterol; 2015 Jun; 8(3):109-15. PubMed ID: 25855582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-Enzymes-Mediated Bioluminescent Sensor for Quantitative and Ultrasensitive Point-of-Care Testing.
    Chen Y; Xianyu Y; Wu J; Dong M; Zheng W; Sun J; Jiang X
    Anal Chem; 2017 May; 89(10):5422-5427. PubMed ID: 28421743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.